OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults
Yuntao Zhang, Yunkai Yang, Q. L. Niu, et al.
Frontiers of Medicine (2022) Vol. 16, Iss. 1, pp. 93-101
Open Access | Times Cited: 23
Yuntao Zhang, Yunkai Yang, Q. L. Niu, et al.
Frontiers of Medicine (2022) Vol. 16, Iss. 1, pp. 93-101
Open Access | Times Cited: 23
Showing 23 citing articles:
Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
Zhifei Chen, Fangqin Xie, Hairong Zhang, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access | Times Cited: 1
Zhifei Chen, Fangqin Xie, Hairong Zhang, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access | Times Cited: 1
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial
Xuanyi Wang, Syed Faisal Mahmood, Fang Jin, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1910-1919
Open Access | Times Cited: 38
Xuanyi Wang, Syed Faisal Mahmood, Fang Jin, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1910-1919
Open Access | Times Cited: 38
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
Haoyue Cheng, Zhicheng Peng, Shuting Si, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 798-798
Open Access | Times Cited: 31
Haoyue Cheng, Zhicheng Peng, Shuting Si, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 798-798
Open Access | Times Cited: 31
Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
Chao Wang, Linyi Chen, Qing‐Bin Lu, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 920-920
Open Access | Times Cited: 25
Chao Wang, Linyi Chen, Qing‐Bin Lu, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 920-920
Open Access | Times Cited: 25
Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China
Yufang Sun, Hang Dai, Ping Wang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 15
Yufang Sun, Hang Dai, Ping Wang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 15
Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study
Lin Tang, Yanyang Zhang, Fuzhen Wang, et al.
BMJ Open (2022) Vol. 12, Iss. 11, pp. e063919-e063919
Open Access | Times Cited: 13
Lin Tang, Yanyang Zhang, Fuzhen Wang, et al.
BMJ Open (2022) Vol. 12, Iss. 11, pp. e063919-e063919
Open Access | Times Cited: 13
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial
Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, et al.
Vaccine (2023) Vol. 41, Iss. 32, pp. 4648-4657
Open Access | Times Cited: 8
Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, et al.
Vaccine (2023) Vol. 41, Iss. 32, pp. 4648-4657
Open Access | Times Cited: 8
An overview of protein-based SARS-CoV-2 vaccines
Yogesh R. Suryawanshi
Vaccine (2023) Vol. 41, Iss. 42, pp. 6174-6193
Closed Access | Times Cited: 8
Yogesh R. Suryawanshi
Vaccine (2023) Vol. 41, Iss. 42, pp. 6174-6193
Closed Access | Times Cited: 8
Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population
Javeria Aijaz, Shakir Hussain, Fouzia Naseer, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 692-692
Open Access | Times Cited: 10
Javeria Aijaz, Shakir Hussain, Fouzia Naseer, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 692-692
Open Access | Times Cited: 10
Dynamic immunogenicity after primary and booster inactivated SARS‐CoV‐2 vaccination in people living with HIV: A longitudinal observational study
Ting Lu, Zhiwei Chen, Yu Cao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 5
Ting Lu, Zhiwei Chen, Yu Cao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 5
Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study
Gui-Ping Wen, Min Zhu, Lirong Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Gui-Ping Wen, Min Zhu, Lirong Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
Zhengchao Lv, Songqin Lv, Qin Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Zhengchao Lv, Songqin Lv, Qin Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development
Xinghang Li, Fengyuan Zeng, Rong Yue, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 120-120
Open Access | Times Cited: 1
Xinghang Li, Fengyuan Zeng, Rong Yue, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 120-120
Open Access | Times Cited: 1
Third dose of anti-SARS-CoV-2 inactivated vaccine for patients with RA: Focusing on immunogenicity and effects of RA drugs
Ting Zhao, Bo Wang, Jiayan Shen, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 5
Ting Zhao, Bo Wang, Jiayan Shen, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 5
Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 study)
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Effectiveness of a third dose of COVID-19 vaccines against delta variant of SARS-COV-2: A Serbian cohort study
Nataša Djordjević, Sanja Matić, Dragan Milovanović, et al.
Srpski arhiv za celokupno lekarstvo (2023) Vol. 151, Iss. 9-10, pp. 518-524
Open Access | Times Cited: 2
Nataša Djordjević, Sanja Matić, Dragan Milovanović, et al.
Srpski arhiv za celokupno lekarstvo (2023) Vol. 151, Iss. 9-10, pp. 518-524
Open Access | Times Cited: 2
Acceptance, safety, and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in patients with primary biliary cholangitis
Haolong Li, Xu Wang, S. Wang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28405-e28405
Open Access
Haolong Li, Xu Wang, S. Wang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28405-e28405
Open Access
The comparison of Immune response to Third booster dose with of ChAdOx-1 or BNT162b2 COVID-19 vaccine in healthcare workers after receiving two doses of CoronaVac
Auchara Tangsathapornpong, Sudatip Kositamongkol, Pornpimon Angkasekwinai, et al.
Research Square (Research Square) (2024)
Open Access
Auchara Tangsathapornpong, Sudatip Kositamongkol, Pornpimon Angkasekwinai, et al.
Research Square (Research Square) (2024)
Open Access
Development and Evaluation of a Rapid Neutralizing Antibody Assay for COVID-19 Vaccination
Heshan Yu, Huan Liu, Yongju Yang, et al.
ACS Omega (2022) Vol. 7, Iss. 41, pp. 36254-36262
Open Access | Times Cited: 2
Heshan Yu, Huan Liu, Yongju Yang, et al.
ACS Omega (2022) Vol. 7, Iss. 41, pp. 36254-36262
Open Access | Times Cited: 2
Efficacy of Heterologous Boosting Using Recombinant SARS-CoV-2 Fusion Protein Vaccine: A Randomized, Double-Blind and Placebo-Controlled Phase III Trial
Xuanyi Wang, Syed Faisal Mahmood, Fang Jin, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
Xuanyi Wang, Syed Faisal Mahmood, Fang Jin, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
Antibody titers of individuals vaccinated for COVID-19: A systematic review
Aminoddin M Domado, Homobono Jacob F Adaza, Andrea Pauline Nicole C Beltran, et al.
Journal of Biosciences (2023) Vol. 48, Iss. 3
Closed Access
Aminoddin M Domado, Homobono Jacob F Adaza, Andrea Pauline Nicole C Beltran, et al.
Journal of Biosciences (2023) Vol. 48, Iss. 3
Closed Access
Vaccine inequity-induced COVID-19 dilemma: Time to sober up (Preprint)
Fei Chen, Shuhui Li, Xinyu Liu, et al.
JMIR Public Health and Surveillance (2022)
Open Access
Fei Chen, Shuhui Li, Xinyu Liu, et al.
JMIR Public Health and Surveillance (2022)
Open Access
